Načítá se...

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Retinal capillary closure induced by hyperglycemia is the principal pathophysiologic abnormality underlying diabetic retinopathy, but the mechanisms by which this induction occurs are not clear. Treatment of diabetic rats for 26 weeks with aminoguanidine, an inhibitor of advanced glycosylation produ...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hammes, H P, Martin, S, Federlin, K, Geisen, K, Brownlee, M
Médium: Artigo
Jazyk:Inglês
Vydáno: 1991
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC53174/
https://ncbi.nlm.nih.gov/pubmed/1763069
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!